Global Bead Based Flow Cytometry Market, By Products (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services), Application (Research Applications, Clinical Application, Industrial Applications), End User (Academic and Research Institutes Pharmaceutical and Biotechnology Companies, Hospitals, Clinical Testing Laboratories, Blood Bank, Others) – Industry Trends and Forecast to 2030.
Bead Based Flow Cytometry Market Analysis and Size
Traditional methods such as microscopy and chemical or immunological stains, test cultures with selective media or target cells, or serological assays have successfully identified infectious agents in biological specimens or environmental samples. However, as veterinary, medical, and public health concerns have grown, faster and more accurate diagnostic tools have been sought. Multiplex array-based assays allow for the rapid and simultaneous measurement of a variety of biomarkers within specimens (Robertson and Nicholson, 2005). Multiplex bead-based flow cytometric immunoassays have recently been developed and applied, and they show great promise for improving the study, diagnosis, and therapeutic management of infectious diseases. Increased R&D efforts by many prominent players for the development of multicolour assays as well as cutting-edge analytical reagents are driving the market.
Data Bridge Market Research analyses that the bead based flow cytometry market which was USD 1.3 billion in 2022, is expected to reach USD 2.59 billion by 2030, at a CAGR of 9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Bead Based Flow Cytometry Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Products (Reagents and Consumables, Flow Cytometry Instruments, Accessories, Services), Application (Research Applications, Clinical Application, Industrial Applications), End User (Academic and Research Institutes Pharmaceutical and Biotechnology Companies, Hospitals, Clinical Testing Laboratories, Blood Bank, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
BIOMÉRIEUX (France), Bio-Rad Laboratories, Inc. (U.S.), Mechatronics (U.S.), Sony Biotechnology Inc. (U.S.), BD (U.S.), Merck KGaA (Germany), Luminex Corporation (U.S.), Miltenyi Biotec (Germany), Danaher (U.S.), Coriolis Pharma (Germany), Sysmex Corporation (Japan), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies Inc. (U.S.), Stratedigm, Inc. (U.S.) and Apogee Electronics Corp (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Flow cytometry is a biophysical, laser-based analytical technology that measures and analyses various physical properties of cells or particles suspended in a fluid when passed through a laser beam. It has several advantages over traditional analytical methods such as ELISA, including delivering precise and accurate results in less time and at roughly the same cost. It is widely used in academic and clinical research and in diagnosing diseases such as HIV, cancer, and haematological malignancies.
Global Bead Based Flow Cytometry Market Dynamics
Drivers
- Increasing stem cell research
The bead based flow cytometry market is anticipated to grow over the next few years due to a significant increase in the use of flow cytometry techniques in clinical trials and research projects. The growing prevalence of cancer and HIV/AIDS and technological developments are anticipated to attract many players, accelerating market expansion. Additionally, it is anticipated that the rising stem cell research and the expanding availability of novel application-specific flow cytometry products will promote market expansion in the near future.
- Rising applications of flow cytometry in medicine and research
Flow cytometry has a wide range of applications, including detecting and measuring protein expression and post-translational modifications such as cleaved and phosphorylated proteins. Another application is immunotyping, which uses fluorescence-conjugated antibodies to detect specific proteins on the surface of cells. This can also be used to determine transfection efficiency when expressing a gene using a marker such as GFP. These all applications will propel the growth of market.
Opportunities
- Rising prevalence of chronic diseases
The rising prevalence and incidence of chronic diseases are expected to drive market growth for cytometry devices. As more diseases are discovered, the global market expands as more companies invest in research and development. As a result, there is a huge demand for advancements in disease diagnosis through quick and accurate techniques.
For instance, According to a World Health Organization report, cancer became the leading cause of death in 2020, with approximately 10 million cases, with the majority of cases being breast cancer (2.26 million), lung cancer (2.21 million), colon and rectum cancer (1.93 million), prostate cancer (1.41 million), skin cancer (1.20 million), and stomach cancer (1.20 million). As a result, the bead based flow cytometry market is experiencing increased demand.
Restraints/Challenges
- High cost of flow cytometry instruments
Flow cytometers are available in various shapes and sizes, with benchtop instruments being the most common. They provide optimal data analysis, ease of use, and upgrades and options for various systems, all to resolve customized separations, cell/particle sorting, exploratory cell analysis, and other issues. Flow cytometers all share three components: fluids, optics, and electronics/informatics. Flow cytometers are very expensive, especially when repair and maintenance are considered.
This bead based flow cytometry market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bead based flow cytometry market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Bead Based Flow Cytometry Market
The COVID-19 outbreak had a substantial impact on the bead based flow cytometry market. The growing use of flow cytometry techniques in research and clinical trials has created numerous opportunities for market participants. For instance, in 2020, Cytek Biosciences Inc. provided funding to researchers and clinicians worldwide who were investigating the impact of the COVID-19 virus on human immune systems.
Global Bead Based Flow Cytometry Market Scope
The bead based flow cytometry market is segmented on the basis of products, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products
- Reagents and Consumables
- Dyes
- Antibodies
- Beads
- Others
- Flow Cytometry Instruments
- Cell analyzers
- Cell sorters
- Accessories
- Services
Application
- Research Applications
- Pharmaceutical and biotechnology
- Apoptosis
- Immunology
- Cell sorting/ screening
- Cell cycle analysis
- Cell transfection/viability
- Cell counting
- Others
- Clinical Application
- Cancer
- Hematology
- Immunodeficiency diseases
- Organ transplantation
- Others
- Industrial Applications
End User
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals
- Clinical Testing Laboratories
- Blood Bank
- Others
Bead Based Flow Cytometry Market Regional Analysis/Insights
The bead based flow cytometry market is analyzed and market size insights and trends are provided by country, products, application and end-user as referenced above.
The countries covered in the bead based flow cytometry market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bead based flow cytometry market due to the availability of supportive government reforms for the development of advanced technologies for molecular diagnostics, the presence of a large number of clinical research labs and major pharmaceuticals in the United States.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the presence of untapped opportunities, rapid economic development, and rising patient awareness levels.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The bead based flow cytometry market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for bead based flow cytometry market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bead based flow cytometry market. The data is available for historic period 2011-2021.
Competitive Landscape and Bead Based Flow Cytometry Market Share Analysis
The bead based flow cytometry market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bead based flow cytometry market.
Some of the major players operating in the bead based flow cytometry market are:
- BIOMÉRIEUX (France)
- Bio-Rad Laboratories, Inc. (U.S.)
- Mechatronics (U.S.)
- Sony Biotechnology Inc. (U.S.)
- BD (U.S.)
- Merck KGaA (Germany)
- Luminex Corporation (U.S.)
- Miltenyi Biotec (Germany)
- Danaher (U.S.)
- Coriolis Pharma (Germany)
- Sysmex Corporation (Japan)
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- Agilent Technologies Inc. (U.S.)
- Stratedigm, Inc. (U.S.)
- Apogee Electronics Corp (U.S.)
SKU-